These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30194702)

  • 1. Initial presentation of human papillomavirus-related head and neck cancer: A retrospective review.
    Khalid MB; Ting P; Pai A; Russo JL; Bakst R; Chai RL; Teng MS; Genden EM; Miles BA
    Laryngoscope; 2019 Apr; 129(4):877-882. PubMed ID: 30194702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral health and human papillomavirus-associated head and neck squamous cell carcinoma.
    Mazul AL; Taylor JM; Divaris K; Weissler MC; Brennan P; Anantharaman D; Abedi-Ardekani B; Olshan AF; Zevallos JP
    Cancer; 2017 Jan; 123(1):71-80. PubMed ID: 27571516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LRG1 and SDR16C5 protein expressions differ according to HPV status in oropharyngeal squamous cell carcinoma.
    Randén-Brady R; Carpén T; Hautala LC; Tolvanen T; Haglund C; Joenväärä S; Mattila P; Mäkitie A; Lehtonen S; Hagström J; Silén S
    Sci Rep; 2024 Jun; 14(1):14148. PubMed ID: 38898137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus and oropharyngeal cancer, the epidemics, and significance of additional clinical biomarkers for prediction of response to therapy (Review).
    Dalianis T
    Int J Oncol; 2014 Jun; 44(6):1799-805. PubMed ID: 24676623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative Circulating Tumor HPV DNA and Oropharyngeal Squamous Cell Disease.
    Lam D; Sangal NR; Aggarwal A; Rajasekaran K; Cannady SB; Basu D; Chalian A; Weinstein G; Brody RM
    JAMA Otolaryngol Head Neck Surg; 2024 May; 150(5):444-450. PubMed ID: 38573644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of human papillomavirus on oropharyngeal cancer biology and response to therapy: implications for treatment.
    Bonilla-Velez J; Mroz EA; Hammon RJ; Rocco JW
    Otolaryngol Clin North Am; 2013 Aug; 46(4):521-43. PubMed ID: 23910468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cause-specific mortality in HPV+ and HPV- oropharyngeal cancer patients: insights from a population-based cohort.
    Nørregaard C; Grønhøj C; Jensen D; Friborg J; Andersen E; von Buchwald C
    Cancer Med; 2018 Jan; 7(1):87-94. PubMed ID: 29171183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Explainable prediction model for the human papillomavirus status in patients with oropharyngeal squamous cell carcinoma using CNN on CT images.
    Fanizzi A; Comes MC; Bove S; Cavalera E; de Franco P; Di Rito A; Errico A; Lioce M; Pati F; Portaluri M; Saponaro C; Scognamillo G; Troiano I; Troiano M; Zito FA; Massafra R
    Sci Rep; 2024 Jun; 14(1):14276. PubMed ID: 38902523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus associated oropharyngeal cancer now the most common mucosal head and neck cancer in Queensland.
    Porceddu SV; Negrello T; Rawson N; Dunn N; Batstone M; Collins M; Dowthwaite S; Hughes BG; Kenny L; Ladwa R; Panizza B; Cossio D
    J Med Imaging Radiat Oncol; 2024 Jun; 68(4):472-480. PubMed ID: 38654618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effects of Gross Cranial Nerve Invasion on Oncologic Outcomes in Patients with HPV(+)OPSCC.
    Zhu A; O'Byrne TJ; Haller TJ; Martin E; Moore EJ
    Laryngoscope; 2024 Jan; 134(1):170-177. PubMed ID: 37254916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of Liquid Biopsy for Diagnosis and Surveillance of Human Papillomavirus-Associated Oropharyngeal Cancer.
    Ferrandino RM; Chen S; Kappauf C; Barlow J; Gold BS; Berger MH; Westra WH; Teng MS; Khan MN; Posner MR; Misiukiewicz KJ; Bakst RL; Sindhu KK; Genden EM; Chai RL; Roof SA
    JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):971-977. PubMed ID: 37422913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treponema denticola chymotrypsin-like protease as associated with HPV-negative oropharyngeal squamous cell carcinoma.
    Kylmä AK; Jouhi L; Listyarifah D; Mohamed H; Mäkitie A; Remes SM; Haglund C; Atula T; Nieminen MT; Sorsa T; Hagström J
    Br J Cancer; 2018 Jul; 119(1):89-95. PubMed ID: 29930251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical, morphologic and molecular heterogeneity of HPV-associated oropharyngeal cancer.
    Lim YX; Mierzwa ML; Sartor MA; D'Silva NJ
    Oncogene; 2023 Sep; 42(40):2939-2955. PubMed ID: 37666939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment Delay and HPV Status on OPSCC With Upfront Surgery: Analysis of National Cancer Database.
    Vasudev M; Martin E; Frank MI; Meller LLT; Haidar YM
    Otolaryngol Head Neck Surg; 2024 Jul; 171(1):124-137. PubMed ID: 38532532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time to change perspectives on HPV in oropharyngeal cancer. A systematic review of HPV prevalence per oropharyngeal sub-site the last 3 years.
    Haeggblom L; Ramqvist T; Tommasino M; Dalianis T; Näsman A
    Papillomavirus Res; 2017 Dec; 4():1-11. PubMed ID: 29179862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The "new" head and neck cancer patient-young, nonsmoker, nondrinker, and HPV positive: evaluation.
    Deschler DG; Richmon JD; Khariwala SS; Ferris RL; Wang MB
    Otolaryngol Head Neck Surg; 2014 Sep; 151(3):375-80. PubMed ID: 24925311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated AJCC Restaging for Oropharyngeal Cancer Research.
    Safranek CW; Wilkins SG; Shah R; Mehra S
    Otolaryngol Head Neck Surg; 2024 Feb; 170(2):627-629. PubMed ID: 37855637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Papilloma Virus Positive Oropharyngeal Squamous Cell Carcinoma and the Immune System: Pathogenesis, Immunotherapy and Future Perspectives.
    Khoo A; Boyer M; Jafri Z; Makeham T; Pham T; Khachigian LM; Floros P; Dowling E; Fedder K; Shonka D; Garneau J; O'Meara CH
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trimodality therapy for HPV-positive oropharyngeal cancer: A population-based study: Trimodality therapy for HPV+ OPC.
    Sanford NN; Hwang WL; Pike LRG; Lam AC; Royce TJ; Mahal BA
    Oral Oncol; 2019 Nov; 98():28-34. PubMed ID: 31536843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-cell analysis reveals cellular and molecular factors counteracting HPV-positive oropharyngeal cancer immunotherapy outcomes.
    Cha J; Kim DH; Kim G; Cho JW; Sung E; Baek S; Hong MH; Kim CG; Sim NS; Hong HJ; Lee JE; Hemberg M; Park S; Yoon SO; Ha SJ; Koh YW; Kim HR; Lee I
    J Immunother Cancer; 2024 Jun; 12(6):. PubMed ID: 38857913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.